טריויד 200 מ"ג תמיסה לאינפוזיה תוך ורידית

Land: Israel

Sprache: Hebräisch

Quelle: Ministry of Health

Wirkstoff:

OFLOXACIN 2 MG/ML

Verfügbar ab:

SANOFI - AVENTIS ISRAEL LTD

ATC-Code:

J01MA01

Darreichungsform:

SOLUTION FOR INFUSION

Verabreichungsweg:

I.V

Hergestellt von:

SANOFI - AVENTIS DEUTSCHLAND GMBH, GERMANY

Therapiegruppe:

OFLOXACIN

Anwendungsgebiete:

Infections of kidney, urinarty tract, genital organs, respiratory tract, chronic and recurrent ear, nose and throat, skin and soft tissues, bones and joints, bacterial enteritis, abdominal cavity, including pelvis minor and septicemia caused by ofloxacin sensitive microorganisms. Prevention of infections in patients with a signifcant reduction of resistance to infections,

Berechtigungsdatum:

2010-11-01